Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cesar Pico-Navarro"'
Autor:
Ravi A Madan, Christopher Heery, Claudia Palena, Caroline Jochems, Julius Strauss, Marijo Bilusic, Fatima Karzai, Jennifer L Marté, Charalampos Floudas, Peter J DeMaria, Katherine Lee-Wisdom, Angie Schwab, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Externí odkaz:
https://doaj.org/article/37a0f2d29a6c47d6940c4dc1bf5400ca
Autor:
Guru P. Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X. Wei, Kerry L. Kilbridge, Richard J. Lee, Evan Y. Yu, Michael Thomas Schweizer, Robert B. Montgomery, Heather H. Cheng, Andrew Caleb Hsieh, Rohit Jain, Jaspreet S. Grewal, Cesar Pico-Navarro, Zarina Gafoor, Teresa Perschy, Petros Grivas
Publikováno v:
Cancer Immunology, Immunotherapy. 72:775-782
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Purpose:BN-CV301 is a poxviral-based vaccine comprised of recombinant (rec.) modified vaccinia Ankara (MVA-BN-CV301; prime) and rec. fowlpox (FPV-CV301; boost). Like its predecessor PANVAC, BN-CV301 contains transgenes encoding tumor-associated antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3f5b25865fb0afb72c49d7fca8cbf1
https://doi.org/10.1158/1078-0432.c.6528519
https://doi.org/10.1158/1078-0432.c.6528519
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Supplementary Table S1A: Phenotypic analysis of surface markers on human DCs transfected with MVA-BN-CV301 and FPV-CV301 vectors Supplementary Table S1B: Activation of CEA- and MUC1-specific T-cells by MVA-BN-CV301 and FPV-CV301 Supplementary Table S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a56f2d1ae1207bb367dea6c1ad6c8e4
https://doi.org/10.1158/1078-0432.22473483.v1
https://doi.org/10.1158/1078-0432.22473483.v1
Autor:
Sonia Bellfield, Sammy Elsamra, Rebecca Dolan, Mahir Maruf, Piyush K. Agarwal, Cesar Pico Navarro, Thomas L. Jang, Beatriz Walter Rodriguez, Siobhan Telfer, Joanna Shih, Ragheed Saoud, James L. Gulley, Andrea B. Apolo, Eric A. Singer, Reema Railkar, Vladimir Valera, Renee Donohue, Jeffrey Schlom, Lambros Stamatakis, Maria J. Marino, Robert Weiss, Sam J. Brancato
Publikováno v:
Journal of Urology. 206
Autor:
Jennifer L. Marte, Katherine Lee-Wisdom, Renee N. Donahue, Charalampos S. Floudas, Ravi A. Madan, Borys Korchin, Caroline Jochems, Jeffrey Schlom, Angie Schwab, Jason M. Redman, Fatima Karzai, Claudia Palena, Peter Joseph DeMaria, Eva Dombi, James L. Gulley, Brigitte C. Widemann, Marijo Bilusic, Tatiana Adams, Julius Strauss, Cesar Pico-Navarro, Christopher R. Heery
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundMVA-BN-brachyury-TRICOM is a recombinant vector-based therapeutic cancer vaccine designed to induce an immune response against brachyury. Brachyury, a transcription factor overexpressed in advanced cancers, has been associated with treatmen
Autor:
Cesar Pico Navarro, Julius Strauss, Jaydira Del Rivero, Eva M. Wagner, Ravi A. Madan, Alanvin Orpia, Christopher R. Heery, Claudia Palena, James L. Gulley, Elizabeth Lamping, Lisa M. Cordes, Margaret E. Gatti-Mays, Jason M. Redman, Jennifer L. Marte, Andrea Burmeister, Renee N. Donahue, Jeffrey Schlom
Publikováno v:
Clinical Cancer Research. 25:4933-4944
Purpose: BN-CV301 is a poxviral-based vaccine comprised of recombinant (rec.) modified vaccinia Ankara (MVA-BN-CV301; prime) and rec. fowlpox (FPV-CV301; boost). Like its predecessor PANVAC, BN-CV301 contains transgenes encoding tumor-associated anti
Autor:
Marijo Bilusic, Ravi A. Madan, Fatima Karzai, Julius Strauss, Jennifer L. Marte, Katherine Lee-Wisdom, Renee N. Donahue, Jason M. Redman, Peter Joseph DeMaria, Charalampos S. Floudas, Borys Korchin, Houssein Abdul Sater, Tatiana Adams, Caroline Jochems, Jeffrey Schlom, Claudia Palena, James L. Gulley, Guenter Silbernagl, Cesar Pico-Navarro
Publikováno v:
Journal of Clinical Oncology. 39:2617-2617
2617 Background: Brachyury is a member of the T-box family of transcription factors which is overexpressed in several tumor types and has been associated with treatment resistance, epithelial to mesenchymal transition and metastatic potential. MVA-BN
Publikováno v:
Journal of Clinical Oncology. 35:124-125
Autor:
Kantoff PW; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; James L. Gulley, National Cancer Institute, Bethesda, MD; and Cesar Pico-Navarro, Bavarian Nordic, Redwood City, CA., Gulley JL; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; James L. Gulley, National Cancer Institute, Bethesda, MD; and Cesar Pico-Navarro, Bavarian Nordic, Redwood City, CA., Pico-Navarro C; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; James L. Gulley, National Cancer Institute, Bethesda, MD; and Cesar Pico-Navarro, Bavarian Nordic, Redwood City, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jan; Vol. 35 (1), pp. 124-125. Date of Electronic Publication: 2016 Sep 30.